ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data

There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint inhibitor therapy, results of a small study suggest.

Related Keywords

Massachusetts ,United States ,Boston ,Jordan ,American ,Prashanth Rajarajan ,Department Of Neurology ,Harvard Medical School ,American Academy Of Neurology ,Medscape Medical ,American Academy ,Medscape Medical News ,Justin Jordan ,Massachusetts General Hospital ,Multiple Sclerosis Ms ,S Multiple Sclerosis ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Biologic Therapy ,Iologics ,Skin Cancer ,Alignant Skin Neoplasm ,Lung Cancer ,Ung Carcinoma ,Ancer Of The Lung ,Malignant Head And Neck Neoplasm ,Head And Neck Cancer ,Ead And Neck Cancer Hnc ,Toxicology ,Toxicity ,Poisoning ,Toxins ,Autoimmune Disease ,